China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use

New protein-based vaccine to be used as booster jab, local media reports
Фото: Anadolu 05.09.2022 265

China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, cites Anadolu.

Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.

Subscribe to our Telegram channel and be the first to know the news!